Hisamitsu Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HISAMITSU, and when can generic versions of HISAMITSU drugs launch?
HISAMITSU has two approved drugs.
There are eight US patents protecting HISAMITSU drugs.
There are fifty-four patent family members on HISAMITSU drugs in eighteen countries and three supplementary protection certificates in three countries.
Summary for Hisamitsu
| International Patents: | 54 |
| US Patents: | 8 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Hisamitsu
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hisamitsu | SECUADO | asenapine | SYSTEM;TRANSDERMAL | 212268-002 | Oct 11, 2019 | RX | Yes | No | 10,814,002 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Hisamitsu | SECUADO | asenapine | SYSTEM;TRANSDERMAL | 212268-001 | Oct 11, 2019 | RX | Yes | Yes | 10,583,121 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Hisamitsu Pharm Co | SALONPAS | menthol; methyl salicylate | PATCH;TOPICAL | 022029-002 | Nov 5, 2012 | OTC | Yes | No | 9,233,184 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Hisamitsu | SECUADO | asenapine | SYSTEM;TRANSDERMAL | 212268-003 | Oct 11, 2019 | RX | Yes | No | 11,123,305 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Hisamitsu Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Taiwan | 201410270 | ⤷ Try a Trial |
| Taiwan | 201410272 | ⤷ Try a Trial |
| World Intellectual Property Organization (WIPO) | 2014017595 | ⤷ Try a Trial |
| Japan | 6286011 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Hisamitsu Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0746317 | C300461 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: ASENAPINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER HET MALEAAT; REGISTRATION NO/DATE: EU/1/10/640/001-006 20100901 |
| 0746317 | 10C0056 | France | ⤷ Try a Trial | PRODUCT NAME: ASENAPINE; REGISTRATION NO/DATE: EU/1/10/640/001 20100901 |
| 0746317 | SPC/GB10/046 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: ASENAPINE; REGISTERED: UK EU/1/10/640/001 20100901; UK EU/1/10/640/002 20100901; UK EU/1/10/640/003 20100901; UK EU/1/10/640/004 20100901; UK EU/1/10/640/005 20100901; UK EU/1/10/640/006 20100901 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
